Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended ...
Iconic actor and filmmaker Manoj Kumar passed away at the age of 87, battling heart conditions and decompensated liver ...
Joel Lewis, Chief Executive Officer and President of Galectin Therapeutics (GALT), said “In the U.S. approximately 5 million adults are ...
Veteran actor Manoj Kumar passes away at 87 due to cardiogenic shock. Understand the causes and symptoms of this severe heart ...
Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...
5d
Health on MSNWhat Is the Difference Between MAFLD and MASH?Medically reviewed by Jay N. Yepuri, MD Metabolic dysfunction-associated fatty liver disease (MAFLD) occurs when excess fat builds up in the liver. MAFLD can progress to metabolic ...
Telma H is manufactured by Glenmark Pharmaceuticals and is prescribed for controlling high blood pressure, particularly in ...
Out of a target population of 92.34 lakh people, only 34 lakh individuals have been screened so far in the state. Of those, ...
The global wearable blood pressure monitor market is witnessing a significant surge, with total market valuation reaching USD 1.8 billion in 2021. As consumer preference for real-time health ...
These medicines are prescribed to treat conditions like chest infections such as pneumonia, metabolic disorder, high blood ...
3d
The Print on MSNPunjab’s war on drugs is an asymmetric fight. Poor infra, not enough doctors or dataPunjab reported 33,000 drug-related cases between 2022 & 2024, second only to Kerala. While a police crackdown is limited to ...
The coronary stent market in India has reached a crucial milestone, with a valuation of USD 843.8 million in 2023, reflecting a transformative shift in the country’s approach to cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results